Jim Cramer Defended American Superiority and Discussed These 13 Stocks

11. Abbott Laboratories (NYSE:ABT)

Number of Hedge Fund holders: 66

Abbott Laboratories (NYSE:ABT) was discussed in the context of a strong earnings report and potential guidance increase before tariffs. Cramer described it as a “tour de force quarter” and applauded CEO Robert Ford’s leadership. Here’s what he said:

“By the way, can we just be sure Abbott did not miss. That’s a COVID test that’s coming down. And Abbott is the first one that I’m beginning to see.  […]

Dollar weakness coming. It’s going to help them. Where do they build their factories? In the United States. For the United States. Overseas. For overseas. David, they are on fire when it comes to so many different line items, including heart. Diagnostics are pretty good. Baby food, if they continue to have a problem with it.

I’ve got to tell you with some of that stuff that they’re doing with that lawsuit, they’re not going to just sit there and take it. I thought that Robert Ford did a remarkable job. Tour de force quarter, people should listen to how you can raise numbers. Do it right. By the way, they kept numbers flat, but raised numbers on a weak dollar. And I just am just amazed at how good they are. That’s a Miles White legacy, Robert Ford keeping it going. The only week this was because of the COVID, the test you can still get. What a quarter.”